Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
progesterone receptor (PR)
LE135 provokes nociceptive responses and elicited thermal hyperalgesia mainly through TRPV1 channels
1-100 nM) shiftes the concentration-response curve for extracellular Ca2+ to the left without affecting the maximal response and
1-100 μM) increases the intracellular Ca2+ concentration
Relugolix Catalog No.:M18801-C progesterone receptor (PR)Relugolix (TAK 385) is a potent, orally active, nonpeptidic gonadotropin releasing hormone (GnRH) antagonist. Relugolix possesses high affinity and potent antagonistic activity for human receptor (binding IC50=0. 33 nM) and monkey receptor (IC50=0. 32 nM) compared with TAK 013 (HY 100209). Relugolix is used for the study of sex hormone dependent diseases, such as including endometriosis, uterine fibroids and prostate cancer et al. Product information
US$ 24.95
US$ 65.00
US$ 269.50
US$ 245.00
US$ 75.05
US$ 99.99